We welcome the comments of Dr. Paz and Dr. Shinfeld to our article entitled ‘Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: A single-centre real-world experience’ [1].
We agree with them that the Beck-II [2] procedure has little in common with the coronary sinus reducer as the first is a surgical operation while the second is a percutaneous intervention. However, the concept of narrowing the coronary sinus is similar and this is what we believe makes the two procedures conceptually comparable (interestingly both procedures aim at a residual lumen diameter in the coronary sinus around 3 mm).
Anzeige
We are also pleased to read the personal experience of the colleagues with the coronary sinus reducer. Specifically the possible physio-pathological explanation of the mechanism by which the coronary sinus reducer can exert its function (neovascularisation) is appealing. We only regret we do not have the possibility to read the original data of their preclinical studies as we could not find any pertinent publication with the data briefly mentioned by the colleagues in their letter.
Funding
None.
Conflict of interest
P. Agostoni and M. Abawi state that they have no competing interest.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.